| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.19 | 0.009 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.17 | 0.4 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.15 | 0.3 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.3 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |